mitoxantrone has been researched along with Carcinoma, Renal Cell in 4 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izumi, K | 1 |
| Kanno, H | 1 |
| Umemoto, S | 1 |
| Hasumi, H | 1 |
| Osada, Y | 1 |
| Otai, J | 1 |
| Mikata, K | 1 |
| Tsuchiya, F | 1 |
| Nagashima, Y | 1 |
| van Oosterom, AT | 1 |
| Fosså, SD | 1 |
| Pizzocaro, G | 1 |
| Bergerat, JP | 1 |
| Bono, AV | 1 |
| De Pauw, M | 1 |
| Sylvester, R | 1 |
| Oliver, RT | 1 |
| Miller, RM | 1 |
| Mehta, A | 1 |
| Barnett, MJ | 1 |
| Gams, RA | 1 |
| Nelson, O | 1 |
| Birch, R | 1 |
1 trial available for mitoxantrone and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.
Topics: Adult; Anthraquinones; Antineoplastic Agents; Carcinoma, Renal Cell; Clinical Trials as Topic; Drug | 1986 |
3 other studies available for mitoxantrone and Carcinoma, Renal Cell
| Article | Year |
|---|---|
[A case of recurrent renal cell carcinoma which recurred after fourth surgical resection and survived for about 2 years by medroxyporgesterone acetate administration].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Ce | 2007 |
Mitoxantrone in advanced renal cancer: a phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.
Topics: Adult; Aged; Anthraquinones; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Evaluation; Female; | 1984 |
A phase 2 study of surveillance in patients with metastatic renal cell carcinoma and assessment of response of such patients to therapy on progression.
Topics: BCG Vaccine; Carcinoma, Renal Cell; Drug Evaluation; Follow-Up Studies; Humans; Interferon Type I; K | 1988 |